Explore how the liver functions, common liver conditions, and tips to maintain liver health through lifestyle changes like ...
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...
Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.
When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
Hosted on MSN23d
Vertex's Pain Drug: Big Pharma's Next Major Success?Vertex's ambitions extend beyond cystic fibrosis and pain management. The company has a healthy and diversified pipeline targeting various diseases, including sickle cell disease (SCD ...
Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
9d
GlobalData on MSNFDA approves Vertex’s acute pain treatment JournavxThe FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results